Cerebrovascular risk factors in early-onset dementia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 6, 2012, Pages 666-667

  Atkins, Emily R ^a   Bulsara, Max K ^b   Panegyres, Peter K ^a  

^a Neurodegenerative Disorders Research Pty Ltd   (Australia)

^b UNIVERSITY OF NOTRE DAME   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ALZHEIMER DISEASE; APOE EPSILON4 GENE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE DOSAGE; GENE EXPRESSION; HEAD INJURY; HETEROZYGOSITY; HUMAN; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; MALE; MARKER GENE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84860902856     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.202846     Document Type: Letter

References (5)

1. Knopman D, Mosley T, Catellier D, et al. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI study. Alzheimers Dement 2009;5:207-14.
2. Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology 2009;73:674-80.
3. Panegyres PK, Goldblatt J, Walpole I, et al. Genetic testing for Alzheimer's disease. Med J Aust 2000;172:339-43. (Pubitemid 30202883)
4. Panegyres PK, Frencham K. The course and causes of suspected dementia in young adults: a longitudinal study. AJADOD 2007;22:48-56. (Pubitemid 46339251)
5. Duron E, Rigaud A, Dubail D, et al. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease. Am J Hypertens 2009;22:1020-24.